A detailed history of Wade G W & Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Wade G W & Inc holds 5,943 shares of MRNA stock, worth $218,999. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,943
Previous 6,514 8.77%
Holding current value
$218,999
Previous $673,000 12.18%
% of portfolio
0.02%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$69.51 - $104.43 $39,690 - $59,629
-571 Reduced 8.77%
5,943 $591,000
Q3 2023

Nov 08, 2023

BUY
$96.41 - $126.61 $189,927 - $249,421
1,970 Added 43.35%
6,514 $673,000
Q2 2023

Aug 10, 2023

SELL
$118.5 - $160.53 $32,350 - $43,824
-273 Reduced 5.67%
4,544 $552,000
Q1 2023

May 09, 2023

BUY
$135.66 - $197.02 $11,531 - $16,746
85 Added 1.8%
4,817 $740,000
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $46,049 - $81,705
389 Added 8.96%
4,732 $850,000
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $34,594 - $56,894
293 Added 7.23%
4,343 $514,000
Q2 2022

Aug 09, 2022

BUY
$117.13 - $176.59 $90,424 - $136,327
772 Added 23.55%
4,050 $579,000
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $4,299 - $7,991
34 Added 1.05%
3,278 $565,000
Q4 2021

Feb 09, 2022

SELL
$225.82 - $368.51 $392,023 - $639,733
-1,736 Reduced 34.86%
3,244 $824,000
Q3 2021

Nov 03, 2021

SELL
$221.9 - $484.47 $568,064 - $1.24 Million
-2,560 Reduced 33.95%
4,980 $1.92 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $104,187 - $188,453
802 Added 11.9%
7,540 $1.77 Million
Q1 2021

May 05, 2021

BUY
$109.18 - $185.98 $48,257 - $82,203
442 Added 7.02%
6,738 $882,000
Q4 2020

Feb 03, 2021

BUY
$65.74 - $169.86 $15,185 - $39,237
231 Added 3.81%
6,296 $658,000
Q3 2020

Nov 09, 2020

BUY
$54.34 - $94.85 $95,910 - $167,410
1,765 Added 41.05%
6,065 $429,000
Q2 2020

Aug 07, 2020

BUY
$29.67 - $80.0 $127,581 - $344,000
4,300 New
4,300 $276,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wade G W & Inc Portfolio

Follow Wade G W & Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.